Michael Mollerus

Davis Polk advised Uniti Group Inc., as issuer, in connection with a new SEC-registered at-the-market offering program by Uniti under which Uniti may issue and sell shares of its common…

Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering of 89,333,920 of its Class A ordinary shares, which included an…

Davis Polk advised the sales agent in connection with an SEC-registered at-the-market offering by Applied Therapeutics, Inc. of shares of its common stock for up to a maximum offering…

Davis Polk advised Aptiv PLC in connection with a $1.1 billion SEC-registered offering of 15,149,519 ordinary shares (which included 1,976,024 ordinary shares that the underwriters…

Davis Polk advised Clarivate Plc in connection with the $1.08 billion SEC-registered offering of 48,000,000 of its ordinary shares, of which 14,000,000 ordinary shares were issued and sold…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of $1.25 billion aggregate principal amount of its 1.350%…

Davis Polk is advising SS&C Technologies Holdings, Inc. on its $120 million acquisition of Innovest Systems, LLC. The transaction is expected to close in the second quarter of 2020. SS…

Davis Polk advised the joint book-running managers and representatives of the underwriters in an SEC-registered offering by General Dynamics Corporation of $750 million aggregate…

Davis Polk advised SS&C Technologies Holdings, Inc. on its acquisition of Captricity. Financial terms of the transaction were not disclosed. SS&C is a global provider of services…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of €500 million aggregate principal amount of its 0.000…